← Back to Search

Dietary Supplement

Arm 1 before Cross Over for Sleep Quality

N/A
Waitlist Available
Research Sponsored by 4Life Research, LLC
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Study Summary

The primary objective of this study is to evaluate the effects of a proprietary oral supplement on the sleep health and quality of people with sleep problems. It is a double-blinded placebo-controlled crossover clinical study.

Eligible Conditions
  • Sleep Quality
  • Sleep Hygiene

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Insomnia Severity Index Score
Saliva Melatonin level changes
Secondary outcome measures
Leeds Sleep Evaluation Questionnaire (LSEQ) Score
Sleep Efficiency
Sleep Onset Latency
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Group I: Arm 2 after Cross OverExperimental Treatment2 Interventions
In Arm 2, Supplement Group and Placebo Group cross over. After a 1-week washout period, and both group will take whatever product they did not take in Arm 2, for 2 week.
Group II: Arm 1 before Cross OverExperimental Treatment2 Interventions
Participants were randomized and divided into two groups: Supplement Group and Placebo Group. In this Arm 1, participants first go through a 1-week washout period, and then take either Supplement or Placebo as assigned for 2 week.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sleep Supplement
2021
N/A
~30
Placebo
1995
Completed Phase 3
~2670

Find a Location

Who is running the clinical trial?

4Life Research, LLCLead Sponsor
5 Previous Clinical Trials
180 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~9 spots leftby Apr 2025